Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

11.1%

1 terminated/withdrawn out of 9 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

11%

1 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

3 recruiting1 with results

Enrollment Performance

Analytics

N/A

7(77.8%)

Phase 4

1(11.1%)

Phase 1

1(11.1%)

9Total

N/A(7)

Phase 4(1)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT07298408Phase 1Recruiting

Cannabidiol for the Treatment of Diabetic Peripheral Neuropathy: Pilot Study

Role: lead

NCT05921201Not ApplicableRecruiting

Preventing Depression of Chinese American Adolescents by RRE

Role: collaborator

NCT06542640Not ApplicableRecruiting

Mechanisms of Response to Therapeutic Intervention in Clinical High Risk (CHR) for Psychosis

Role: collaborator

NCT05514002Phase 4Terminated

Comparison of Recombinant Influenza Vaccine Versus Standard Egg-Based Inactivated Influenza Vaccine in Adults 18-64 Years

Role: collaborator

NCT06741241Not ApplicableNot Yet Recruiting

Effectiveness of an EHealth Intervention for Uptake of Cervical Cancer Screening in Hispanic Women

Role: lead

NCT04304001Not ApplicableCompleted

Test Up Now Education Program

Role: lead

NCT03545685Not ApplicableCompleted

Intervention of Attenuated Psychosis Syndrome With M-Health Technology

Role: lead

NCT03339050Not ApplicableCompleted

Reducing Cardiovascular Risk of African Americans

Role: collaborator

NCT01123759Not ApplicableCompleted

Healthful Seafood Consumption for Sensitive Populations

Role: collaborator

All 9 trials loaded